Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Smoking Cessation 1Smoking 1Sinonasal undifferentiated carcinoma 1Radiation Injuries 1Paranasal Sinus Neoplasms 1Oropharyngeal Neoplasms 1NSCLC 1Lung Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1Glioblastoma 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Cardiovascular Diseases 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1

Interventions

dehydroftorafur 1Radiotherapy 1Radiation 1Platinum 1Fluorouracil 1Docetaxel 1Cisplatin 1Chemoradiotherapy 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Sinonasal undifferentiated carcinoma × Chemoradiotherapy × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡